NCT01508455View on ClinicalTrials.gov

Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Anesthesia

Interventions

DRUG

Dexmedetomidine

DRUG

Midazolam

DRUG

Fentanyl

DRUG

Morphine

Trial Locations (4)

15224

Pittsburgh

26506

Morgantown

29605

Greenville

40202

Louisville

All Listed Sponsors

lead

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT01508455 - Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age | Biotech Hunter | Biotech Hunter